Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease

Jeffrey R. Liddell(The University of Melbourne), Rachel Codd(University of Sydney)
Free Radical Biology and Medicine
February 5, 2013
Cited by 30


Related Papers